Othman Alfleesy*


This study presents a novel approach to treating snakebite envenoming, which aims to enhance the neutralization of venom in bitten individuals to reduce adverse reactions and mortality rates. The traditional antivenom treatment, produced from horse serum by Albert Calmette in 1895, has been found to be ineffective, unsafe, and life-threatening, and the search for an effective and safe alternative has been ongoing for years. This study offers a practical proposal for the treatment of snakebite envenoming by hypothesizing that the infusion of (O)negative blood group, a natural substance, can enhance the neutralization of venom and increase the production of human innate immunoglobulins, thereby improving the chances of survival for bitten individuals. The significance of this proposal lies in its potential to provide an alternative to the current, inadequate treatment options for snakebite envenoming. The urgency for a solution is further highlighted by the lack of success in developing an effective and safe antivenom. Using(O) negative blood group for the treatment of snakebite envenoming presents an attractive alternative that avoids the risks associated with the use of horse serum antivenom. Additionally, this method has been found to have potent efficacy in accelerating the neutralization of snake venom and improving the chances of survival. This study contributes to the existing knowledge by proposing a unique approach to the treatment of snakebite envenoming. The proposal offers a basis for further research and clinical trials to confirm its safety and efficacy and to explore the development of additional innovative treatment options for snakebite envenoming. In conclusion, this study represents a significant contribution to reducing the high mortality rate associated with snakebites and improving the survival prospects of affected individuals.

Keywords: New snakebite envenoming treatment, neutralization, Calmette antivenom, human innate immunoglobulins (antibodies), blood group (O) negative.

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation


    MARCH 2023 Issue has been successfully launched on 1 MARCH 2023.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction